# A Drug Interaction Study of Simvastatin and Albiglutide

> **NCT01147692** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 40 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **BIOLOGICAL:** simvastatin plus albiglutide

## Key facts

- **NCT ID:** NCT01147692
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-19
- **Primary completion:** 2010-08-27
- **Final completion:** 2010-08-27
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147692, "A Drug Interaction Study of Simvastatin and Albiglutide". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01147692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*